How shall we generate antibody designs that balance affinity, specificity, developability, manufacturability, and safety while clearly quantifying model confidence?

How shall we integrate formulation and CMC constraints into in silico design (pI, charge patches, hydrophobic patches)?

How does AI flag high risk motifs, e.g cytokine release risk, immune activation